Key result
The Lordsdale Genotype II SRSV EIA identified SRSVs in 71% of positive gastroenteritis outbreaks, comparing favorably to electron microscopy and RT-PCR.
Why the study?
Does an EIA based on recombinant capsid protein accurately detect SRSV in gastroenteritis outbreaks compared to EM and RT-PCR?
Observational (n=305)
No
Does an EIA based on recombinant capsid protein accurately detect SRSV in gastroenteritis outbreaks compared to EM and RT-PCR?
The Lordsdale Genotype II SRSV EIA provides a simple, cost-effective assay with improved sensitivity over EM for detecting circulating SRSV strains in UK outbreaks.
Answers are grounded in this paper and cite their sources.
May simplify outbreak diagnostics over EM; leaves open prospective validation versus RT-PCR.
Small round structured viruses (SRSVs) are the major cause of outbreaks of gastroenteritis in the UK. Diagnosis is problematic due to insensitive electron microscopy (EM) or technically demanding reverse transcription polymerase chain reaction (RT-PCR) techniques. We have studied outbreaks of non-bacterial gastroenteritis using an EIA based upon recombinant capsid protein from the currently prevalent circulating strain of SRSV (Lordsdale Genotype II) and compared its performance against EM and RT-PCR assays. Faecal specimens sent to the Bristol Public Health Laboratory for outbreak investigation from December 1996 to December 1997 were applied retrospectively to the SRSV EIA and results compared with the routine EM and RT-PCR that had been carried out prospectively. Overall, the three tests identified SRSVs in specimens from 70% of the outbreaks (213/305) investigated. Of the 213 total positive outbreaks, the EIA identified 71%, that compared favourably with EM (63%) and RT-PCR (84%). The Lordsdale Genotype II SRSV EIA provides a simple cost-effective assay that will for the first time make detection of currently circulating SRSV strains associated with UK outbreaks available to all routine laboratories. The EIA format makes the assay widely applicable to non-specialist laboratories, unlike the RT-PCR assay, and the improved sensitivity over EM will allow successful screening of UK outbreaks alongside commercial EIAs currently available for adenovirus, astrovirus and rotavirus. Furthermore, the assay will allow rapid identification of emerging SRSV strains.
No takes yet. Share an insight, caveat, or question.
Vipond et al. (2000) conducted an observational in Gastroenteritis outbreaks (n=305). Lordsdale Genotype II SRSV EIA vs. Electron microscopy (EM) and RT-PCR was evaluated on Detection of SRSVs in positive outbreaks. The Lordsdale Genotype II SRSV EIA identified SRSVs in 71% of positive gastroenteritis outbreaks, comparing favorably to electron microscopy and RT-PCR.
Synapse has enriched 10 related papers. Consider them for comparative context: